Creative Medical Technology Holdings, Inc.
CELZ
$2.21
-$0.07-3.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -45.45% | -45.45% | -64.71% | 55.56% | 22.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -45.45% | -45.45% | -64.71% | 55.56% | 22.22% |
| Cost of Revenue | -50.00% | -45.45% | -64.71% | 55.56% | 22.22% |
| Gross Profit | -42.42% | -45.45% | -64.71% | 55.56% | 22.22% |
| SG&A Expenses | 16.18% | 16.79% | 7.15% | -0.13% | -9.01% |
| Depreciation & Amortization | 11.58% | 1.41% | 5.70% | 10.91% | 16.93% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.85% | 7.94% | -2.55% | 11.63% | 2.23% |
| Operating Income | -6.95% | -8.04% | 2.37% | -11.56% | -2.20% |
| Income Before Tax | -9.13% | -12.10% | -0.59% | -15.42% | -3.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.13% | -12.10% | -0.59% | -15.42% | -3.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.13% | -12.10% | -0.59% | -15.42% | -3.91% |
| EBIT | -6.95% | -8.04% | 2.37% | -11.56% | -2.20% |
| EBITDA | -6.85% | -8.18% | 2.52% | -11.57% | -1.95% |
| EPS Basic | 32.37% | 24.47% | 22.87% | -0.70% | 2.20% |
| Normalized Basic EPS | 32.36% | 24.47% | 22.87% | -0.70% | 2.20% |
| EPS Diluted | 32.37% | 24.47% | 22.87% | -0.70% | 2.20% |
| Normalized Diluted EPS | 32.36% | 24.47% | 22.87% | -0.70% | 2.20% |
| Average Basic Shares Outstanding | 65.93% | 57.93% | 35.76% | 14.83% | 5.17% |
| Average Diluted Shares Outstanding | 65.93% | 57.93% | 35.76% | 14.83% | 5.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |